MARIE
| Reference number | |
| Coordinator | Oxlantic Medical AB |
| Funding from Vinnova | SEK 1 879 300 |
| Project duration | April 2024 - December 2025 |
| Status | Completed |
| Venture | Swelife - Samverkansprojekt för bättre hälsa |
| Call | Swelife - Collaborative projects for better health autumn 2023 |
Important results from the project
Yes, and the project became even larger and more important than planned because Karolinska´s participation resulted in a PhD position and doubled the number of studies. The project also resulted in clinical data necessary for the CE marking of MARIE.
Expected long term effects
A product that will meet the healthcare´s needs and increase patient safety through continuous respiratory monitoring in new clinical settings. MARIE will likely become standard in many healthcare settings around the world. Thanks to the project, Swedish research in respiratory monitoring and capnography is strengthened. More studies are planned to be carried out in 2026. The project has also contributed to a collaboration between Uppsala and Karolinska.
Approach and implementation
The planned activities were right and well balanced and the team’s competence created positive synergy effects. The collaboration worked excellently and the great interest from the healthcare sector was unexpectedly positive. Karolinska´s unplanned participation contributed to the project being particularly successful and at the same time opened up a collaboration between Uppsala Universitet, Region Uppsala, Karolinska Institutet and Regionen Stockholm regarding research on MARIE.